Takeuchi A - Search Results

1

Effect of KRN2391 on canine ventricular arrhythmia models.

Takeuchi A, Harada K, Miwa A, Jinno Y, Kaneta S, Yokoyama T, Ogawa N. Takeuchi A, et al. Gen Pharmacol. 1994 Jan;25(1):53-60. doi: 10.1016/0306-3623(94)90009-4. Gen Pharmacol. 1994. PMID: 8043150

2

Vasospasmolytic effect of KRN2391 on 3,4-diaminopyridine-induced rhythmic contraction of porcine coronary artery.

Miwa A, Takeuchi A, Fukata Y, Izumi H, Izawa T, Ogawa N. Miwa A, et al. Among authors: takeuchi a. Gen Pharmacol. 1994 Oct;25(6):1171-8. doi: 10.1016/0306-3623(94)90134-1. Gen Pharmacol. 1994. PMID: 7875541

3

KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.

Kawahara J, Jinno Y, Endo M, Izumi H, Takeuchi A, Izawa T. Kawahara J, et al. Among authors: takeuchi a. J Cardiovasc Pharmacol. 1997 Jun;29(6):814-9. doi: 10.1097/00005344-199706000-00016. J Cardiovasc Pharmacol. 1997. PMID: 9234664

4

In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives.

Izumi H, Kawahara J, Takeuchi A, Izawa T, Ogawa N. Izumi H, et al. Among authors: takeuchi a. Fundam Clin Pharmacol. 1997;11(6):561-6. doi: 10.1111/j.1472-8206.1997.tb00861.x. Fundam Clin Pharmacol. 1997. PMID: 9444524

5

Effects of the K+ channel opener KRN4884 on the cardiovascular metabolic syndrome model in rats.

Okada Y, Yoshino T, Takeuchi A, Endoh M, Ohta H, Jinno Y, Yokoyama T, Izawa T, Kobayshi E. Okada Y, et al. Among authors: takeuchi a. J Cardiovasc Pharmacol. 2000 Feb;35(2):287-93. doi: 10.1097/00005344-200002000-00017. J Cardiovasc Pharmacol. 2000. PMID: 10672863

6

Effects of pegylated recombinant human megakaryocyte growth and development factor on 5-fluorouracil-induced thrombocytopenia in balloon-injured rats.

Harada K, Tazunoki Y, Ide Y, Takeuchi A, Kawahara J, Suzuki T. Harada K, et al. Among authors: takeuchi a. J Pharm Pharmacol. 2000 Mar;52(3):321-5. doi: 10.1211/0022357001773869. J Pharm Pharmacol. 2000. PMID: 10757421

7

Enhancement by endothelin-1 of the release of catecholamines from the canine adrenal gland in response to splanchnic nerve stimulation.

Takeuchi A, Kimura T, Satoh S. Takeuchi A, et al. Clin Exp Pharmacol Physiol. 1992 Sep;19(9):663-6. doi: 10.1111/j.1440-1681.1992.tb00519.x. Clin Exp Pharmacol Physiol. 1992. PMID: 1395110

8

Effects of pirenzepine and AF-DX 116 on ganglionic transmission in the cardiac sympathetic nerves of the dog: interaction of M1 and M2 receptors with nicotinic receptors.

Mukaiyama O, Takeuchi A, Kimura T, Satoh S. Mukaiyama O, et al. Among authors: takeuchi a. J Pharmacol Exp Ther. 1991 Feb;256(2):525-9. J Pharmacol Exp Ther. 1991. PMID: 1704433

9

Effects of nifedipine and Bay-K-8644 on the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation.

Takeuchi A, Kimura T, Satoh S. Takeuchi A, et al. Clin Exp Pharmacol Physiol. 1993 Jan;20(1):35-9. doi: 10.1111/j.1440-1681.1993.tb01500.x. Clin Exp Pharmacol Physiol. 1993. PMID: 7679341

10

Inhibition by omega-conotoxin GVIA of adrenal catecholamine release in response to endogenous and exogenous acetylcholine.

Kimura T, Takeuchi A, Satoh S. Kimura T, et al. Among authors: takeuchi a. Eur J Pharmacol. 1994 Oct 24;264(2):169-75. doi: 10.1016/0014-2999(94)00459-5. Eur J Pharmacol. 1994. PMID: 7851479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,836 results

Search Page

Filters